|
21 May 2020 |
IMV Announces Selection of a Vaccine Candidate Against COVID-19 to Advance Into Human Clinical Studies
|
|
21 May 2020 |
CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine
|
|
21 May 2020 |
AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
|
|
20 May 2020 |
Vaxart Announces Selection of its Oral COVID-19 Vaccine Lead Candidate
|
|
20 May 2020 |
INOVIO’s COVID-19 DNA vaccine INO-4800 demonstrates robust neutralizing antibody and T cell immune responses in preclinical models
|
|
19 May 2020 |
PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology
|
|
19 May 2020 |
Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate
|
|
18 May 2020 |
GreenLight Biosciences raises $17M financing round to accelerate large-scale manufacturing of future COVID-19 vaccines
|
|
18 May 2020 |
Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
|
|
15 May 2020 |
Medicago Announces Positive Results in Animal Trials for Its Vaccine Candidate Against COVID-19
|
|
14 May 2020 |
INOVIO's INO-5401 in Combination with PD-1 Inhibitor Libtayo® (cemiplimab) Demonstrates 85% of Newly Diagnosed Glioblastoma Patients Are Alive 12 Months Following Treatment
|
|
14 May 2020 |
Pfizer Announces Positive Top-Line Results From Phase 3 Lot Consistency Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naive Adults 18 Through 49 Years of Age
|
|
14 May 2020 |
CureVac´s Optimized mRNA Platform Provides Positive Pre-Clinical Results at Low Dose for Coronavirus Vaccine Candidate
|
|
14 May 2020 |
VAXIMM Announces First Results from Phase I/II Trial in Progressive Glioblastoma with Oral T-cell Immunotherapy VXM01 in Combination with PD-L1 Inhibitor Avelumab to be Presented at ASCO20 Virtual
|
|
12 May 2020 |
Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
|
|
11 May 2020 |
TolerogenixX Reports Positive Phase Ib Data of its Lead Product to Combat Transplant Rejection
|
|
08 May 2020 |
ZYUS Collaborates with USask’s VIDO-InterVac to Develop a Plant-Based Vaccine for COVID-19
|
|
06 May 2020 |
Predictive Oncology and Dr. Daniel Carter Collaborating to Develop a Potential COVID-19 Vaccine Utilizing Novel Nanoparticle Vaccine Platform, Based on NSP-10
|
|
06 May 2020 |
OSE Immunotherapeutics Announces COVID-19 Prophylactic Vaccine Program
|
|
06 May 2020 |
CEPI seeks to expand COVID-19 vaccine portfolio, focusing on speed and global manufacturing
|
|
05 May 2020 |
Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
|
|
04 May 2020 |
Applied DNA and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals
|
|
04 May 2020 |
Stallergenes Greer Submits a Marketing Authorisation Application in Europe for Its Sublingual House Dust Mite Allergen Immunotherapy Tablet
|
|
01 May 2020 |
Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) Against Novel Coronavirus
|
|
30 Apr 2020 |
INOVIO expands manufacturing of COVID-19 DNA vaccine INO-4800 with new funding from CEPI
|
